Kidney transplant blood test study
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study looks at how well a new blood test works to monitor kidney health after a transplant. It might help doctors catch problems early without needing a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old.
- Be getting a kidney transplant (or have had one within the last 29 days).
- Be willing to have extra blood tests as part of your regular care.
- Not have had a transplant of any other organ (like heart or liver) before.
- Not be pregnant or planning to become pregnant in the next 2 years.
- No history of bleeding or blood clotting problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a blood test that looks for tiny pieces of the donor's DNA in your blood to check how your new kidney is doing. It may help doctors monitor your transplant and spot problems early, possibly without needing a biopsy.
This study looks at kidney transplant patients who are getting a kidney biopsy for usual clinical reasons. It tests whether special blood test results (from a sample taken as part of the study) can help spot transplant kidney problems earlier or more accurately.
This trial uses a personalized approach (including tacrolimus medication planning and monitoring) to better understand how a kidney transplant is doing. It may help your transplant team tailor care to your kidney function over time.
This trial is testing a new blood test called T-ID that monitors your immune system after a kidney transplant. It may help doctors detect early signs of rejection so they can adjust your treatment before problems start.
This trial is testing a new blood test (called TreaT-Assay) to help diagnose acute rejection after a kidney transplant. The goal is to catch rejection earlier and more accurately, so you can get the right treatment faster.
This study looks at how the body’s immune system responds when a kidney transplant shows signs of rejection, using a planned kidney biopsy. It may help doctors better understand what drives rejection and how to improve care in the future.
Hear when a new Biomarkers / Blood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.